Results 81 to 90 of about 18,898 (135)

A brain reward circuit inhibited by next-generation weight-loss drugs in mice. [PDF]

Nature
Godschall EN, Gungul TB, Sajonia IR, Buyukaksakal AK, Li O, Ogilvie S, Keeler AB, Tian G, Shi Y, Koita O, Guo CX, Deutsch TCJ, Steacy EJ, Crook M, Zhang Y, Conley NJ, Memi G, Webster AN, Yipkin Calhan O, Liu W, Akkoub A, Malik K, West KI, Michel-Le S, Karthikeyan A, van Gerven G, Dell'Aglio OA, Beier KT, Zweifel LS, Patel MK, Campbell JN, Deppmann CD, Güler AD.   +32 more
europepmc   +1 more source

A rapid review of the effects of GLP-1 receptor agonists on opioid and stimulant use-related outcomes. [PDF]

Drug Alcohol Depend Rep
Leach M, Marziali ME, Parashar S, Bondy G, Guillemi S, Harris M, Hull M, Stone S, Kooij KW, Hogg RS, Montaner JSG.   +10 more
europepmc   +1 more source

MC4R-related monogenic obesity in children: insights from 2 cases. [PDF]

Ann Pediatr Endocrinol Metab
Shanmugam D, Sridhar S, Kuppusamy N, Manjini K, Sreenivasan P, Kumar MA.   +5 more
europepmc   +1 more source

Comparative efficacy and safety of three fixed-ratio combination products in type 2 diabetes: A network meta-analysis. [PDF]

J Diabetes Investig
Wang X, Qin J, Liu Y, Wang X.
europepmc   +1 more source

GLP1 receptor agonists in heart failure with preserved ejection fraction (HFpEF) - beyond weight loss: a condensed scientific review. [PDF]

Drugs Context
Roy E, Parent MC, Ducharme A.
europepmc   +1 more source

Effectiveness of GLP-1 Receptor Agonists in Patients With Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. [PDF]

Cureus
Buragohain S, Sarma I, Saikia D, Malakar H, Das BK, Khound M, Lahon J.   +6 more
europepmc   +1 more source

Disproportionality Analysis of Tirzepatide vs. Semaglutide and Liraglutide: System Organ Class-Level Post-Marketing Reporting Patterns in EudraVigilance. [PDF]

Int J Mol Sci
Marin RC, Vesa CM, Tit DM, Radu AF, Bungau GS.   +4 more
europepmc   +1 more source

Impact of Liraglutide on Insulin Clearance in Patients with Type 2 Diabetes Mellitus: Evidence from a Randomized Controlled Trial. [PDF]

Diabetes Metab J
Boelling M, Pu J, Shen J, Retnakaran R.
europepmc   +1 more source

GLP-1 therapies and hair loss: A systematic review of current evidence and implications for counseling. [PDF]

Sci Prog
Gupta AK, Teasell EM, Economopoulos V, Mirmirani P.   +3 more
europepmc   +1 more source

Exploring the Use of GLP-1-Based Interventions for Obesity: A Qualitative Analysis of ClinicalTrials.gov Data. [PDF]

Diabetes Metab Syndr Obes
Alourfi NM, Alorfi NM.
europepmc   +1 more source